<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>Oleic acid (C18:1) is_biomarker_for Breast cancer response to chemotherapy — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>Oleic acid (C18:1)</strong>
  <span class="pred">&mdash;is_biomarker_for&rarr;</span>
  <strong>Breast cancer response to chemotherapy</strong>
</div>
<div class="entity-id">HMDB:HMDB0000207 &nbsp;&middot;&nbsp; MESH:D001943</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:100%;--color:#2ca02c"></div>
<div class="stat-row">
  <span>Class: Physical (10.0)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 3.90<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; Curated 0.5 &middot; AI 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts 0.8). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#2ca02c" title="Physical"></span><span>Physical</span><a href="https://doi.org/10.1002/ijc.28491">10.1002/ijc.28491</a> <a href="https://www.ebi.ac.uk/metabolights/MTBLS92">MTBLS92</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 9 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:100px"></span><span>3</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">oxaliplatin — increases → phosphatidylglycerol (PG)</span><a href="../claim/a09b0eddce81cd82.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">oxaliplatin — increases → phosphatidylcholine (PC)</span><a href="../claim/e1150355b6f04ca3.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">oxaliplatin — decreases → neutral lipid metabolism</span><a href="../claim/f2477f3132d5ebe8.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:100px"></span><span>3</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">oxaliplatin — increases → phosphatidic acid (PA)</span><a href="../claim/fa556cee80fdbf55.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">oxaliplatin — is_biomarker_for → colorectal cancer</span><a href="../claim/9084a14e24b3ef56.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">lipid profile signature — distinguishes → oxaliplatin-treated vs. control HT29 colorectal cancer cells</span><a href="../claim/c841ec8edb9e2540.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:100px"></span><span>3</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">oxaliplatin — increases → phosphatidylethanolamine with PUFA chains (PE-PUFA)</span><a href="../claim/962e85c73cd3f3cb.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">oxaliplatin — decreases → triacylglycerols with saturated fatty acid chains (TAG-SFA)</span><a href="../claim/2040fc314d560cee.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">oxaliplatin — activates → phospholipid metabolic process</span><a href="../claim/cad7dc6bd82eda1b.html">view &rarr;</a></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>1aa1b963782234d6</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/HMDB:HMDB0000207">HMDB:HMDB0000207</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D001943">MESH:D001943</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
